Dihydroergotamine Mesylate Nasal Spray, Metered
Product Images NDC 69097-503

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Dihydroergotamine Mesylate Nasal (NDC 69097-503). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Eb13b2de 29b4 450d Bafc 396ac7d771b9 01

The text appears to be a chemical formula and name for a specific substance. "Dinydroergotamine mesylate" is a compound with the molecular formula "C28H37N5O4S". The other text "CH,SOH" may possibly be indicating the chemical groups present in the compound, CH (carbon and hydrogen) and SOH (sulfur, oxygen and hydrogen).*

FDA Label Image

Eb13b2de 29b4 450d Bafc 396ac7d771b9 02

FDA Label Image

Eb13b2de 29b4 450d Bafc 396ac7d771b9 03

Estimated probability of patent responding to Hydroergotamine Mesylate Nasal Spray during the four hours following being dosed. Study conducted with 57 participants receiving Hydroergotamine Mesylate Nasal Spray and 100 participants in the placebo group.*

FDA Label Image

Eb13b2de 29b4 450d Bafc 396ac7d771b9 04

This text reports on a study that estimates the probability of patients using additional treatments for migraines in the 24 hours after receiving Dibydroergotamine mesylate (a spray medication at a 2mg dosage) or a placebo. The study included 30 patients who were administered the Dibydroergotamine mesylate spray and 30 who received the placebo.*

FDA Label Image

Eb13b2de 29b4 450d Bafc 396ac7d771b9 05

This is a description for a medication called Dihydroergotamine Mesylate Nasal Spray. The text includes the drug name, its concentration (4mg), and the warning that it's for nasal use only and not for injection. It also provides the name of the manufacturer, Cipla USA, Inc. with its address in Wearten, NJ 07059. At the bottom, there is a reference number "Rov. 42020 S21266 Usa", which could be a batch or lot number for quality control. The first line, "Unvarnished Area for Batch overprinting" indicates a possible requirement for a blank space on the packaging for additional printing, such as the aforementioned reference number.*

FDA Label Image

Eb13b2de 29b4 450d Bafc 396ac7d771b9 06

The text is not readable.*

FDA Label Image

Eb13b2de 29b4 450d Bafc 396ac7d771b9 07

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.